Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Jovana Milic and Giovanni Guaraldi.
Jovana Milic
Connection Strength
4.816
Giovanni Guaraldi
  1. Darunavir/Cobicistat Is Associated with Negative Outcomes in HIV-Negative Patients with Severe COVID-19 Pneumonia. AIDS Res Hum Retroviruses. 2021 04; 37(4):283-291.
    View in: PubMed
    Score: 0.938
  2. The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state study. PLoS One. 2021; 16(8):e0251378.
    View in: PubMed
    Score: 0.240
  3. The Impact of COVID-19 on UNAIDS 90-90-90 Targets: Calls for New HIV Care Models. Open Forum Infect Dis. 2021 Jul; 8(7):ofab283.
    View in: PubMed
    Score: 0.238
  4. Methylprednisolone as rescue therapy after tocilizumab failure in patients with severe COVID-19 pneumonia. Clin Exp Rheumatol. 2021 Sep-Oct; 39(5):1141.
    View in: PubMed
    Score: 0.233
  5. Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection. PLoS One. 2021; 16(2):e0247275.
    View in: PubMed
    Score: 0.233
  6. HIV care models during the COVID-19 era. Clin Infect Dis. 2020 Dec 19.
    View in: PubMed
    Score: 0.230
  7. COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion. Rheumatology (Oxford). 2020 12 01; 59(12):e147-e150.
    View in: PubMed
    Score: 0.229
  8. Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia-Challenges, strengths, and opportunities in a global health emergency. PLoS One. 2020; 15(11):e0239172.
    View in: PubMed
    Score: 0.228
  9. Tocilizumab in COVID-19: finding the optimal route and dose - Authors' reply. Lancet Rheumatol. 2020 Dec; 2(12):e739-e740.
    View in: PubMed
    Score: 0.226
  10. Tocilizumab for severe COVID-19 pneumonia - Authors' reply. Lancet Rheumatol. 2020 Nov; 2(11):e660-e661.
    View in: PubMed
    Score: 0.224
  11. Tocilizumab in patients with severe COVID-19: a retrospective cohort study. Lancet Rheumatol. 2020 Aug; 2(8):e474-e484.
    View in: PubMed
    Score: 0.222
  12. Impact of prolonged maraviroc treatment on non-AIDS-related comorbidities in HIV-positive patients: a retrospective cohort study. J Antimicrob Chemother. 2019 09 01; 74(9):2723-2731.
    View in: PubMed
    Score: 0.210
  13. The Interplay Between Age and Frailty in People Living With HIV: Results From an 11-Year Follow-up Observational Study. Open Forum Infect Dis. 2019 May; 6(5):ofz199.
    View in: PubMed
    Score: 0.206
  14. Molecular Imaging of Vascular Calcification with 18F-Sodium-Fluoride in Patients Infected with Human Immunodeficiency Virus. Int J Mol Sci. 2019 Mar 08; 20(5).
    View in: PubMed
    Score: 0.203
  15. Managing antiretroviral therapy in the elderly HIV patient. Expert Rev Clin Pharmacol. 2018 Dec; 11(12):1171-1181.
    View in: PubMed
    Score: 0.199
  16. Incidence, risk factors and outcome of acute kidney injury (AKI) in patients with COVID-19. Clin Exp Nephrol. 2021 Nov; 25(11):1203-1214.
    View in: PubMed
    Score: 0.060
  17. Disentangling the Association of Hydroxychloroquine Treatment with Mortality in Covid-19 Hospitalized Patients through Hierarchical Clustering. J Healthc Eng. 2021; 2021:5556207.
    View in: PubMed
    Score: 0.060
  18. Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patients. Sci Rep. 2021 06 16; 11(1):12716.
    View in: PubMed
    Score: 0.059
  19. Acid base disorders in patients with COVID-19. Int Urol Nephrol. 2022 Feb; 54(2):405-410.
    View in: PubMed
    Score: 0.059
  20. Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study. Front Med (Lausanne). 2021; 8:639970.
    View in: PubMed
    Score: 0.059
  21. The impact of chest CT body composition parameters on clinical outcomes in COVID-19 patients. PLoS One. 2021; 16(5):e0251768.
    View in: PubMed
    Score: 0.059
  22. Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients. Kidney Res Clin Pract. 2021 Jun; 40(2):231-240.
    View in: PubMed
    Score: 0.059
  23. Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator. Clin Microbiol Infect. 2021 Aug; 27(8):1137-1144.
    View in: PubMed
    Score: 0.058
  24. Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study. Thromb Haemost. 2021 Aug; 121(8):1054-1065.
    View in: PubMed
    Score: 0.058
  25. Hypokalemia in Patients with COVID-19. Clin Exp Nephrol. 2021 Apr; 25(4):401-409.
    View in: PubMed
    Score: 0.058
  26. Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID-19 patients with pneumonia. Eur J Immunol. 2020 09; 50(9):1283-1294.
    View in: PubMed
    Score: 0.056
  27. Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study. Nutr Metab Cardiovasc Dis. 2020 10 30; 30(11):1899-1913.
    View in: PubMed
    Score: 0.056
  28. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia. Nat Commun. 2020 07 06; 11(1):3434.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.